Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.43B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Dianthus Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −16 vs. Q2 2023
- Shares held
- 10.1M
- −19.0M (−65.3%) vs. Q2 2023
- Total value
- $136.3M
- +$114.3M (+519.3%) vs. Q2 2023
- New holders
- 9
- 0 more added
- Sold out
- 25
- 21 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.43B |
| Q1 2026 | 241 | $5.37B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.85B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $859.0M |
| Q2 2024 | 74 | $769.0M |
| Q1 2024 | 76 | $784.0M |
| Q4 2023 | 39 | $109.9M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $70.5M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.6M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $423.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 2,218,212 | $29.0M | 0.00% | +2,218,212 | New |
| Fairmount Funds Management LLC | 1,928,503 | $26.4M | 3.17% | +1,928,503 | New |
| 5AM Venture Management, LLC | 1,472,264 | $20.1M | 5.79% | +1,472,264 | New |
| Avidity Partners Management LP | 1,217,554 | $16.6M | 0.67% | +1,217,554 | New |
| VR Adviser, LLC | 927,706 | $12.7M | 1.33% | +927,706 | New |
| Tang Capital Management LLC | 591,636 | $8.09M | 1.14% | −5,468,364−90.2% | Reduced |
| Octagon Capital Advisors LP | 480,000 | $6.56M | 1.16% | −70,000−12.7% | Reduced |
| Nantahala Capital Management, LLC | 336,862 | $4.60M | 0.58% | −4,663,138−93.3% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 236,979 | $3.24M | 0.50% | −3,554,719−93.8% | Reduced |
| Alphabet Inc. | 208,697 | $2.85M | 0.18% | −3,130,441−93.7% | Reduced |
| Vanguard Group Inc | 126,877 | $1.73M | 0.00% | −1,841,544−93.6% | Reduced |
| Citadel Advisors LLC | 105,561 | $1.44M | 0.00% | −3,254,440−96.9% | Reduced |
| Laurion Capital Management LP | 36,393 | $497.5K | 0.01% | −545,907−93.8% | Reduced |
| Renaissance Technologies LLC | 35,216 | $481.0K | 0.00% | −446,484−92.7% | Reduced |
| BlackRock Inc. | 32,151 | $439.5K | 0.00% | −332,017−91.2% | Reduced |
| Geode Capital Management, LLC | 26,341 | $360.2K | 0.00% | −331,349−92.6% | Reduced |
| Acadian Asset Management LLC | 22,299 | $303.0K | 0.00% | −435,391−95.1% | Reduced |
| ArrowMark Colorado Holdings LLC | 20,788 | $284.2K | 0.00% | +20,788 | New |
| RBF Capital, LLC | 15,676 | $214.3K | 0.01% | −235,146−93.8% | Reduced |
| Bessemer Group Inc | 14,829 | $203.0K | 0.00% | −222,463−93.8% | Reduced |
| Jefferies Financial Group Inc. | 13,200 | $180.4K | 0.00% | +13,200 | New |
| Citigroup Inc | 3,868 | $52.9K | 0.00% | +3,868 | New |
| UBS Group AG | 319 | $4.36K | 0.00% | −10,858−97.1% | Reduced |
| Royal Bank of Canada | 339 | $4.00K | 0.00% | −5,504−94.2% | Reduced |
| Morgan Stanley | 155 | $2.12K | 0.00% | −16,711−99.1% | Reduced |
| Bank of America Corp | 122 | $1.67K | 0.00% | −27,795−99.6% | Reduced |
| Wells Fargo & Company | 50 | $684 | 0.00% | −729−93.6% | Reduced |
| JPMorgan Chase & Co | 41 | $560 | 0.00% | −662−94.2% | Reduced |
| Institutional & Family Asset Management, LLC | 3 | $41 | 0.00% | −47−94.0% | Reduced |
| Qube Research & Technologies Ltd | 3 | $41 | 0.00% | +3 | New |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −378,272−100.0% | Sold out |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −332,610−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −177,400−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −167,454−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −149,300−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −139,207−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −120,269−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −103,302−100.0% | Sold out |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −71,463−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −60,404−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −47,170−100.0% | Sold out |
| Fiduciary Trust Co | 0 | $0 | 0.00% | −30,555−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −27,369−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −26,932−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −12,190−100.0% | Sold out |
| Sound View Wealth Advisors Group, LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −4,474−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −742−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −375−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Pension & Wealth Management Advisors, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |